Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Sempra
SRE
|
$1.89B |
| 2 |
CVS Health
CVS
|
$1.4B |
| 3 |
FedEx
FDX
|
$1.08B |
| 4 |
Intel
INTC
|
$866M |
| 5 |
Celanese
CE
|
$758M |
Top Sells
| 1 |
Humana
HUM
|
$1.73B |
| 2 |
Comcast
CMCSA
|
$1.49B |
| 3 |
Crown Castle
CCI
|
$1.18B |
| 4 |
UnitedHealth
UNH
|
$1.11B |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$972M |
Sector Composition
| 1 | Technology | 21.7% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 13.81% |
| 4 | Industrials | 12.74% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Danaher
DHR
$147B
| $3.63B | 0.92% | 14,621,738 +592,390 | +4% | +$147M |
|
|
27
Intel
INTC
$107B
| $3.42B | 0.87% | 96,299,456 +24,349,192 | +34% | +$866M |
|
28
Netflix
NFLX
$513B
| $3.42B | 0.87% | 9,064,605 -2,102,618 | -19% | -$794M |
|
29
Eli Lilly
LLY
$657B
| $3.3B | 0.84% | 6,139,754 -59,018 | -1% | -$31.7M |
|
30
Constellation Energy
CEG
$96.2B
| $3.21B | 0.81% | 29,429,259 +1,060,141 | +4% | +$116M |
|
31
Equinix
EQIX
$76.9B
| $3.06B | 0.78% | 4,207,983 -385,114 | -8% | -$280M |
|
32
Union Pacific
UNP
$133B
| $2.97B | 0.75% | 14,604,604 +1,258,707 | +9% | +$256M |
|
33
Applied Materials
AMAT
$128B
| $2.95B | 0.75% | 21,323,094 +440,449 | +2% | +$61M |
|
34
Chevron
CVX
$324B
| $2.92B | 0.74% | 17,330,832 -714,133 | -4% | -$120M |
|
35
Charter Communications
CHTR
$36.3B
| $2.83B | 0.72% | 6,445,278 -553,312 | -8% | -$243M |
|
36
Wells Fargo
WFC
$263B
| $2.82B | 0.71% | 68,948,352 +7,114,583 | +12% | +$291M |
|
37
Royal Caribbean
RCL
$98.7B
| $2.67B | 0.68% | 28,957,840 -713,719 | -2% | -$65.8M |
|
38
Zoetis
ZTS
$69.3B
| $2.63B | 0.67% | 15,105,417 -156,614 | -1% | -$27.2M |
|
39
KKR & Co
KKR
$124B
| $2.59B | 0.66% | 42,003,664 +2,257,720 | +6% | +$139M |
|
40
CME Group
CME
$96B
| $2.54B | 0.64% | 12,688,743 -1,308,221 | -9% | -$262M |
|
41
Equifax
EFX
$30.3B
| $2.5B | 0.64% | 13,662,586 +3,071,254 | +29% | +$563M |
|
42
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.45B | 0.62% | 2,974,338 +17,723 | +0.6% | +$14.6M |
|
43
AstraZeneca
AZN
$248B
| $2.34B | 0.59% | 34,618,579 -3,721,186 | -10% | -$252M |
|
44
ConocoPhillips
COP
$124B
| $2.33B | 0.59% | 19,454,366 -2,036,609 | -9% | -$244M |
|
45
ASML
ASML
$292B
| $2.29B | 0.58% | 3,902,656 +5,747 | +0.1% | +$3.38M |
|
46
KLA
KLAC
$115B
| $2.27B | 0.58% | 4,943,150 -439,529 | -8% | -$202M |
|
47
Constellation Brands
STZ
$28.5B
| $2.27B | 0.57% | 9,012,745 +1,109,497 | +14% | +$279M |
|
48
ServiceNow
NOW
$190B
| $2.24B | 0.57% | 4,003,467 -56,832 | -1% | -$31.8M |
|
49
CenterPoint Energy
CNP
$24.6B
| $2.23B | 0.56% | 82,890,001 +12,961,210 | +19% | +$348M |
|
50
Arthur J. Gallagher & Co
AJG
$77.6B
| $2.2B | 0.56% | 9,651,212 +150,382 | +2% | +$34.3M |
|